Natalia Rozwadowska

Prof. Natalia Rozwadowska is a stem cell biologist and translational scientist working at the interface of basic research, advanced therapy development, and clinical implementation. Since 2018, she has headed the Department of Molecular Pathology at the Institute of Human Genetics, Polish Academy of Sciences, and she also serves as Deputy Director for Development of IHG PAS and Research Director at FamiCordTX, where she contributes to the development of cell and gene therapy platforms.
Her scientific background combines over 20 years of experience in stem cell biology, muscle progenitor cells, pluripotent stem cell models, regenerative medicine, and disease modeling. She received her PhD from Poznan University of Medical Sciences and completed postdoctoral training at the University of Alabama at Birmingham. Her academic achievements have been recognized with the Prime Minister’s Awards for outstanding PhD and DSc accomplishments.
In recent years, Prof. Rozwadowska’s work has increasingly focused on Advanced Therapy Medicinal Products, including CAR-T and gene therapy approaches. She has been involved in building one of the first end-to-end CAR-T development and manufacturing pipelines in Poland by FamicordTX, supporting the translation of a locally developed therapy from research and GMP-oriented production toward early clinical evaluation. This experience has shaped her strong interest in practical models of responsible, quality-driven, and patient-oriented cell and gene therapy translation.
Beyond individual projects, Prof. Rozwadowska is actively engaged in strengthening the Polish ATMP and cell and gene therapy ecosystem. As Chair of the Committee for Stem Cells and Cell Therapies of the V Division of Medical Sciences of the Polish Academy of Sciences, she supports initiatives that connect academic science, biotechnology, regulatory perspectives, manufacturing capacity, and clinical needs. She has also led multiple research and development projects, supervised young scientists, and supported academia–industry collaboration, including implementation doctorates and translational research programmes.